A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care
Noninvasive serum biomarkers (nonalcoholic fatty liver disease fibrosis score [NFS], fibrosis 4 score [FIB‐4], or enhanced liver fibrosis [ELF] test) are recommended as first‐line tools to determine the risk of advanced fibrosis in nonalcoholic fatty liver disease. We aimed to assess the utility of...
Main Authors: | PreyaJanubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Anne Bernard, Nigel Neil Brown, Guy Lampe, Lyndall Buck, Nivene Saad, Anthony William Russell, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, William Rosenberg, Elizabeth Ellen Powell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-08-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1208 |
Similar Items
-
Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
by: Preya J. Patel, et al.
Published: (2017-01-01) -
Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation.
by: Victoria L Gadd, et al.
Published: (2016-01-01) -
Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics
by: Harendran Elangovan, et al.
Published: (2020-04-01) -
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
by: Katharine M. Irvine, et al.
Published: (2021-02-01) -
The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study
by: Declan Connoley, et al.
Published: (2021-06-01)